MANA Therapeutics

Jonathan Behr, a US partner at the Dementia Discovery Fund (DDF), sees the increase during the past few years in early-stage investments in neurodegeneration-focused biopharmaceutical companies having

The week before the annual J.P. Morgan Healthcare Conference always includes a bevy of new financings and the week before this year’s 11-14 January meeting kept up with the tradition with $1.67bn in v